Ashley Bonner

2.0k total citations · 1 hit paper
38 papers, 1.4k citations indexed

About

Ashley Bonner is a scholar working on Pathology and Forensic Medicine, Oncology and Rheumatology. According to data from OpenAlex, Ashley Bonner has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 8 papers in Rheumatology. Recurrent topics in Ashley Bonner's work include CAR-T cell therapy research (7 papers), Systemic Sclerosis and Related Diseases (6 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Ashley Bonner is often cited by papers focused on CAR-T cell therapy research (7 papers), Systemic Sclerosis and Related Diseases (6 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Ashley Bonner collaborates with scholars based in Canada, United States and Switzerland. Ashley Bonner's co-authors include Joseph Beyene, Janet Pope, Taddele Kibret, Binod Neupane, Paul Alexander, Gordon Guyatt, Glen Hazlewood, Toshi A. Furukawa, Holger J. Schünemann and Reed Siemieniuk and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Ashley Bonner

37 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis

2017 517 citations Ashley Bonner, Glen Hazlewood et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ashley Bonner Canada	16	280	234	230	214	183	38	1.4k
Élodie Drumez France	24	315 1.1×	357 1.5×	236 1.0×	439 2.1×	180 1.0×	132	1.9k
Robert Nee United States	23	191 0.7×	132 0.6×	197 0.9×	522 2.4×	94 0.5×	77	2.1k
Fung Chang Sung Taiwan	23	182 0.7×	293 1.3×	162 0.7×	234 1.1×	204 1.1×	52	1.3k
Dóra Körmendiné Farkas Denmark	27	267 1.0×	474 2.0×	349 1.5×	470 2.2×	272 1.5×	125	2.4k
Hiangkiat Tan United States	16	201 0.7×	89 0.4×	250 1.1×	242 1.1×	195 1.1×	62	1.2k
Machaon Bonafede United States	28	304 1.1×	399 1.7×	345 1.5×	400 1.9×	356 1.9×	153	2.8k
Wei‐Sheng Chung Taiwan	23	401 1.4×	244 1.0×	125 0.5×	299 1.4×	66 0.4×	73	1.6k
Rachel Court United Kingdom	21	131 0.5×	213 0.9×	210 0.9×	563 2.6×	172 0.9×	66	1.8k
Robert I. Griffiths United States	26	252 0.9×	288 1.2×	215 0.9×	321 1.5×	280 1.5×	75	2.0k
Nigel Armstrong United Kingdom	26	554 2.0×	298 1.3×	126 0.5×	466 2.2×	404 2.2×	88	2.9k

Countries citing papers authored by Ashley Bonner

Since Specialization

Citations

This map shows the geographic impact of Ashley Bonner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Bonner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Bonner more than expected).

Fields of papers citing papers by Ashley Bonner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Bonner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Bonner. The network helps show where Ashley Bonner may publish in the future.

Co-authorship network of co-authors of Ashley Bonner

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Bonner. A scholar is included among the top collaborators of Ashley Bonner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Bonner. Ashley Bonner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Disher, Tim, Myrlene Sanon Aigbogun, Ashley Bonner, et al.. (2025). One-Year Efficacy of Guselkumab Versus Advanced Therapies for the Treatment of Moderately to Severely Active Crohn’s Disease: A Network Meta-Analysis. Advances in Therapy. 42(6). 2708–2727. 2 indexed citations

Nastoupil, Loretta J., et al.. (2025). Matching-adjusted indirect comparison of efficacy and safety of lisocabtagene maraleucel and mosunetuzumab for the treatment of third-line or later relapsed or refractory follicular lymphoma. Experimental Hematology and Oncology. 14(1). 30–30. 1 indexed citations

Abramson, Jeremy S., Manali Kamdar, Alessandro Crotta, et al.. (2024). Matching-Adjusted Indirect Comparison (MAIC) of Lisocabtagene Maraleucel (liso-cel) Versus Axicabtagene Ciloleucel (axi-cel) for Second-Line (2L) Treatment of Patients (pts) with Refractory/Early Relapsed (R/R) Large B-Cell Lymphoma (LBCL): Update with 34 Months of Liso-Cel Follow-up. Blood. 144(Supplement 1). 3130–3130.

Klamroth, Robert, Ashley Bonner, Keith Gomez, et al.. (2023). Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half‐life factor IX therapies for severe or moderately severe haemophilia B. Haemophilia. 30(1). 75–86. 3 indexed citations

Nastoupil, Loretta J., et al.. (2023). Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) and Mosunetuzumab for the Treatment (Tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL). Blood. 142(Supplement 1). 2338–2338. 5 indexed citations

Tsoi, Bernice, Leo E. Akioyamen, Ashley Bonner, et al.. (2017). Comparative Efficacy of Angiotensin II Antagonists in Essential Hypertension: Systematic Review and Network Meta-Analysis of Randomised Controlled Trials. Heart Lung and Circulation. 27(6). 666–682. 15 indexed citations

Ha, Vanessa, et al.. (2017). The effects of various diets on glycemic outcomes during pregnancy: A systematic review and network meta-analysis. PLoS ONE. 12(8). e0182095–e0182095. 17 indexed citations

Bonner, Ashley, et al.. (2015). The effect of forced air warming devices compared to other active warming devices on surgical site contamination: a systematic review protocol. The JBI Database of Systematic Reviews and Implementation Reports. 13(7). 131–141. 1 indexed citations

Bonner, Ashley, Binod Neupane, & Joseph Beyene. (2014). Testing for associations between systolic blood pressure and single-nucleotide polymorphism profiles obtained from sparse principal component analysis. BMC Proceedings. 8(S1). S95–S95. 2 indexed citations

10.

Dennis, Brittany B., Leen Naji, Monica Bawor, et al.. (2014). The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol. Systematic Reviews. 3(1). 105–105. 45 indexed citations

11.

Barra, Lillian, Richard Y. Cao, Nicole Riché, et al.. (2014). Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis for Function and Pain is Affected by Rheumatoid Factor. The Open Rheumatology Journal. 8(1). 73–76. 6 indexed citations

12.

Neupane, Binod, et al.. (2014). Network Meta-Analysis Using R: A Review of Currently Available Automated Packages. PLoS ONE. 9(12). e115065–e115065. 269 indexed citations

13.

Bykerk, Vivian P., Carol Hitchon, Edward Keystone, et al.. (2013). Determining Best Practices in Early Rheumatoid Arthritis by Comparing Differences in Treatment at Sites in the Canadian Early Arthritis Cohort. The Journal of Rheumatology. 40(11). 1823–1830. 22 indexed citations

14.

Bonner, Ashley, et al.. (2013). Low Socioeconomic Status (Measured by Education) and Outcomes in Systemic Sclerosis: Data from the Canadian Scleroderma Research Group. The Journal of Rheumatology. 40(4). 447–454. 11 indexed citations

15.

Bonner, Ashley, et al.. (2013). Association of Gastroesophageal Factors and Worsening of Forced Vital Capacity in Systemic Sclerosis. The Journal of Rheumatology. 40(6). 850–858. 39 indexed citations

16.

Muangchan, Chayawee, et al.. (2012). Association of C‐reactive protein with high disease activity in systemic sclerosis: Results from the Canadian Scleroderma Research Group. Arthritis Care & Research. 64(9). 1405–1414. 85 indexed citations

17.

Pope, Janet, et al.. (2012). Agreement with Guidelines from a Large Database for Management of Systemic Sclerosis: Results from the Canadian Scleroderma Research Group. The Journal of Rheumatology. 39(3). 524–531. 26 indexed citations

18.

Bonner, Ashley, et al.. (2012). Differences in Autoantibody Profiles and Disease Activity and Damage Scores Between Childhood- and Adult-Onset Systemic Lupus Erythematosus: A Meta-Analysis. Seminars in Arthritis and Rheumatism. 42(3). 271–280. 45 indexed citations

19.

Harding, Sarah E, et al.. (2012). Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG).. PubMed. 30(2 Suppl 71). S38–43. 16 indexed citations

20.

Bykerk, Vivian P., Ashley Bonner, Carter Thorne, et al.. (2012). Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort. Lara D. Veeken. 51(9). 1662–1669. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact